Cargando…
Antibody Response in Healthcare Workers before and after the Third Dose of Anti-SARS-CoV-2 Vaccine: A Pilot Study
The SARS-CoV-2 pandemic led to the development of various vaccines. The BNT162b2 mRNA vaccine was the first approved due to its efficacy in eliciting a humoral immunity response after the second dose. However, a decrease in the antibody concentration was observed over time. Therefore, the administra...
Autores principales: | Panico, Alessandra, Lobreglio, Giambattista, Bagordo, Francesco, Zizza, Antonella, De Donno, Antonella, Rosato, Chiara, Lazzari, Roberta, Chicone, Michele, Indino, Floriano, Recchia, Virginia, Alifano, Pietro, Grassi, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229040/ https://www.ncbi.nlm.nih.gov/pubmed/35746470 http://dx.doi.org/10.3390/vaccines10060862 |
Ejemplares similares
-
Kinetics of Humoral Immunity against SARS-CoV-2 in Healthcare Workers after the Third Dose of BNT162b2 mRNA Vaccine
por: Grassi, Tiziana, et al.
Publicado: (2022) -
IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection
por: De Donno, Antonella, et al.
Publicado: (2021) -
Direct detection of free vitamin D as a tool to assess risk conditions associated with chronic plaque psoriasis
por: GRASSI, TIZIANA, et al.
Publicado: (2020) -
Occurrence of Microplastics in Tap and Bottled Water: Current Knowledge
por: Gambino, Isabella, et al.
Publicado: (2022) -
Factors Associated with Pneumonia in Patients Hospitalized with COVID-19 and the Role of Vaccination
por: Zizza, Antonella, et al.
Publicado: (2023)